Brief: Innate Pharma Announces Preclinical Data With Trifunctional Nk Cell Engager In Acute Myeloid Leukemia

Innate Pharma SA

16/01/2023 06:28

Jan 16 (Reuters) - Innate Pharma SA  IPH.PA :
    * INNATE PHARMA ANNOUNCES PUBLICATION OF PRECLINICAL DATA
WITH A
TRIFUNCTIONAL NK CELL ENGAGER IN ACUTE MYELOID LEUKEMIA IN
NATURE BIOTECHNOLOGY
    * DATA SHOW CONTROL OF ACUTE MYELOID LEUKEMIA BY A
TRIFUNCTIONAL
NKP46-CD16A-NK CELL ENGAGER TARGETING CD123
    * THESE RESULTS SUPPORT CLINICAL DEVELOPMENT OF CD123-NKCE;
A
PHASE 1/2 CLINICAL TRIAL BY SANOFI IS ONGOING

Source text for Eikon:  ID:nBw7G6jGma 
Further company coverage:  IPH.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))